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EDITOR’S CHOICE
Preventing clots
The rare death of a younger person as a result of a long airline
journey is sure to hit the press headlines. Death could be due to
venous thrombo-embolism (VTE). As someone with three of the
associated risk factors (on the wrong side of 60, previous deep-
vein thrombosis (DVT) and prolonged immobility) I administer a
jab of a low-molecular-weight heparin (LMWH) to myself just
before takeoff. Apart from their most serious danger of sudden
death due to massive pulmonary embolism, VTEs can
occasionally also cause prolonged disability such as swollen legs. 
VTEs can be prevented by an improved understanding of the
causes, and appropriate prophylaxis and treatment. Prophylactic
anticoagulation in South Africa is unfortunately under-prescribed.
This has led to unacceptable mortality and morbidity in numerous
patients. The guidelines for prophylactic anticoagulation by the
Southern African Society of Thrombosis and Haemostasis (p. 689)
provide an authoritative, pithy but comprehensive outline for use
in South Africa. 
Pulmonary embolus is the commonest preventable cause of
death in hospital patients, contributing 10% of all hospital deaths,
three-quarters of which occur in medically ill patients. In the
absence of anticoagulation, in medically ill patients, the risk of
DVT is comparable with that observed in surgical patients (10 -
20%). The efficacy of heparins in preventing VTEs in surgical and
medically ill patients is well established. However, their use is
associated with an increased risk of major bleeding episodes and
this should be balanced against the thrombotic risk.
High-risk conditions include severe cardiopulmonary disease
(particularly cardiac/respiratory failure), stroke, acute myocardial
infarction, ICU patients, pregnancy, duration of surgical
procedure, degree of tissue damage and degree of immobility
following surgery. Associated risk factors include age above 60
years, past history of VTE, underlying malignancy, obesity,
prolonged immobility, oestrogen replacement therapy and
underlying thrombophilic states. 
The authors provide easy-to-follow recommendations for
prophylaxis in medically ill, surgical and pregnant patients. They
also include recommendations with regard to spinal and epidural
anaesthesia.
Prophylaxis is not required for medical patients who are mobile
or for patients undergoing low-risk surgical procedures with no
patient-related risk factors. In patients at high risk of bleeding, the
use of mechanical prophylaxis such as graduated compression
stockings or intermittent pneumatic compression should be
considered as an alternative if the thrombotic risk is high.
The timing of prophylaxis in surgical patients is controversial
and it seems that 6 hours postoperatively will become the
preferred method. The duration of prophylaxis depends on
factors such as the extent of the surgery and the presence of
additional risk factors. 
Treatment of VTE needs to be individualised according to the
patient’s thrombo-embolic risk level. LMWH offers advantages in
terms of convenient dosing and no need for monitoring. Warfarin
should be commenced from day 2 of anticoagulation and
continued with monitoring of the INR levels.
Treating HIV-infected children 
The changing environment in South Africa in which the
management of HIV/AIDS now includes the provision of
antiretroviral therapy led to the development of an antiretroviral
treatment programme for public sector patients as reported by the
Red Cross Children's Hospital team (p. 643). 
They found that their earlier results were better than published
reports from rich countries. The key to ongoing success is to
ensure that high levels of adherence are maintained. Some
children developed serious medical events during the early stages
of therapy and their experience suggests that an inpatient
consultation service is an important consideration. 
Occupational post-exposure HIV
prophylaxis
With the dramatic increase in the numbers of HIV/AIDS patients
in South Africa the dangers of occupational exposure for health
care workers is much increased. Gary Maartens (p. 626) provides
a logical outline of when and how to provide appropriate post-
exposure prophylaxis (PEP).
In instances where the risk of infection is extremely low or non-
existent, PEP is not indicated, as the risks will far outweigh its
benefits. Low- and high-risk exposures are defined, as are the two
recommended regimens for treatment. PEP should be commenced
as soon as possible after the injury. PEP is not well tolerated, with
adverse events occurring in about half of all cases, although most
of these are not life threatening.
Traditional bonesetters
Traditional healers thrive all over the world. SAMA is
investigating how it should respond to the traditional healers in
South Africa. In China many medical schools attempted to
combine teaching of conventional medicine with traditional
Chinese healing, although they have recently moved their medical
education towards standards of a global nature. 
Nigeria, with about 130 million people, has the largest
population in Africa. Nigeria has 16 medical schools compared
with South Africa where 8 medical schools serve a population of
44 million. Dr Onuminya (p. 652) provides a fascinating insight
into the important role played by traditional bonesetters (TBS) in
his country.
Over 70% of the rural population in Nigeria still rely on the TBS
for primary fracture care. TBS practice also accounts for about
80% of fracture morbidity in their hospitals, with gangrene
resulting from treatment by a TBS accounting for 60% of major
limb amputations in Nigeria. Dr Onuminya provides thoughtful
proposals for upgrading the TBS services.
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